<i>Journal of Hepatology</i>｜Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis

doi:10.12449/JCH2409.gwqkjpwzjj2

Volume 40 Issue 9

Sep. 2024

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2024 > 40(9): 1777-1777

PDF( 909 KB)

Journal of Hepatology｜Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis

DOI: 10.12449/JCH2409.gwqkjpwzjj2

Published Date: 2024-09-25

Abstract

FullText(HTML)

References(0)

References

Relative Articles

[1]	The New England Journal of Medicine｜Xalnesiran with or without an immunomodulator in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2025, 41(1): 62-62. doi: 10.12449/JCH2501.gwqkjpwzjj1
[2]	Journal of Hepatology｜Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway[J]. Journal of Clinical Hepatology, 2025, 41(2): 364-364. doi: 10.12449/JCH2502.gwqkjpwzjj2
[3]	Weiwei YAO, Ruimin JIAO, Kejia LIU, Shuai XU, Li LI, Hong YOU, Jingjie ZHAO. Quality assessment of randomized controlled trials of compound traditional Chinese medicine prescriptions in treatment of nonalcoholic steatohepatitis in 2018—2023[J]. Journal of Clinical Hepatology, 2024, 40(12): 2406-2414. doi: 10.12449/JCH241210
[4]	Journal of Hepatology｜Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis[J]. Journal of Clinical Hepatology, 2024, 40(8): 1537-1537. doi: 10.12449/JCH2408.gwqkjpwzjj1
[5]	Journal of Hepatology｜Capsaicin receptor TRPV1 maintains quiescence of hepatic stellate cells in the liver via recruitment of SARM1[J]. Journal of Clinical Hepatology, 2024, 40(3): 508-508. doi: 10.12449/JCH2403.gwqkjpwzjj1
[6]	Journal of the American Medical Association｜Aspirin for metabolic dysfunction-associated steatotic liver disease without cirrhosis: A randomized clinical trial[J]. Journal of Clinical Hepatology, 2024, 40(8): 1652-1652. doi: 10.12449/JCH2408.gwqkjpwzjj3
[7]	Journal of Hepatology｜An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2024, 40(5): 981-981. doi: 10.12449/JCH2405.gwqkjpwzjj2
[8]	Journal of Hepatology｜An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2024, 40(2): 342-342. doi: 10.12449/JCH2402.gwqkjpwzjj3
[9]	Journal of Hepatology｜Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated[J]. Journal of Clinical Hepatology, 2023, 39(2): 407-407. doi: 10.3969/j.issn.1001-5256.2023.02.gwjpwzjj2
[10]	Hepatology International｜Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial[J]. Journal of Clinical Hepatology, 2023, 39(10): 2431-2431. doi: 10.3969/j.issn.1001-5256.2023.10.gwjpwzjj1
[11]	Journal of Gastroenterology and Hepatology｜Farnesoid X receptor is an important target for the treatment of disorders of bile acid and fatty acid metabolism in mice with nonalcoholic fatty liver disease combined with cholestasis[J]. Journal of Clinical Hepatology, 2023, 39(11): 2523-2523. doi: 10.3969/j.issn.1001-5256.2023.11.gwjpwzjj1
[12]	Journal of Hepatology｜Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity[J]. Journal of Clinical Hepatology, 2022, 38(4): 890-890. doi: 10.3969/j.issn.1001-5256.2022.04.gwjpwzjj2
[13]	Journal of Gastroenterology and Hepatology｜Compared with chemotherapy alone as the first-line treatment, PD-1 inhibitor combined with chemotherapy can significantly improve the median progression-free survival time of patients with metastatic or recurrent cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2022, 38(2): 401-401. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj5
[14]	Journal of Hepatology｜PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(3): 698-698. doi: 10.3969/j.issn.1001-5256.2022.3.gwjpwzjj2
[15]	Hui QUAN, Yuyong JIANG. Role of interleukin-1β in the pathogenesis of alcoholic liver disease[J]. Journal of Clinical Hepatology, 2021, 37(5): 1226-1228. doi: 10.3969/j.issn.1001-5256.2021.05.053
[18]	Lai JingLan, Liu YuMing, Lin Chun, Sun Fang, Zhou Rui, Lin Yong, Lin YuanBao. Correlation between serum interleukin-1 receptor antagonist and disease severity in patients with HBV-related liver failure[J]. Journal of Clinical Hepatology, 2016, 32(5): 890-893. doi: 10.3969/j.issn.1001-5256.2016.05.015
[20]	Chen ZiPing, Liu Qian, Wang WenQi, Yan MingXian. Clinical Study of Serum IL-1β、TNF-α on Bone Metabolism in Patients with Posthepatitic Cirrhosis[J]. Journal of Clinical Hepatology, 2000, 16(4): 216-218.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (180) PDF downloads(13)

Journal of Hepatology｜Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis

DOI: 10.12449/JCH2409.gwqkjpwzjj2

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Journal of Hepatology｜Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis

DOI: 10.12449/JCH2409.gwqkjpwzjj2

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content